{"doi":"10.1111/joim.13771","title":"Mass changes in remnant cholesterol and LDL cholesterol explain part of the results of gemfibrozil and non‐gemfibrozil fibrate trials","abstract":null,"journal":"Journal of Internal Medicine","year":2024,"id":630425,"datarank":0.20794415416798362,"base_score":1.3862943611198906,"endowment":1.3862943611198906,"self_citation_contribution":0.20794415416798362,"citation_network_contribution":0.0,"self_endowment_contribution":0.20794415416798362,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":3,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1633206,"name":"Anne Langsted","orcid":"0000-0002-0201-7223","position":1,"is_corresponding":false},{"id":78545,"name":"Børge G. Nordestgaard","orcid":"0000-0002-1954-7220","position":2,"is_corresponding":false},{"id":1633205,"name":"Takahito Doi","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Mass changes in remnant cholesterol and LDL cholesterol explain part of the results of gemfibrozil and non‐gemfibrozil fibrate trials","abstract":"The data underlying this article cannot be shared publicly because the Danish data protection agency does not allow open access. However, on reasonable request, additional analyses can be done by contacting the corresponding author. Table S1. Absolute changes of lipid traits in PROMINENT, ACCORD, FIELD, BIP, VA-HIT, and HHS. Table S2. Comparison of different gemfibrozil and non-gemfibrozil fibrate trials and CGPS mimicking corresponding trial. Figure S1. Comparison of gemfibrozil and non-gemfibrozil fibrate trials and corresponding Copenhagen General Population Study mimicking trials using calculated LDL cholesterol and remnant cholesterol by the Martin-Hopkins equation. Figure S2. Comparison of gemfibrozil and non-gemfibrozil fibrate trials and corresponding Copenhagen General Population Study mimicking trials using non-HDL cholesterol. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.","is_dataset_classified":null,"base_score":1.3862943611198906,"endowment":1.3862943611198906,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"38343109","pmcid":null,"openalex_id":"https://openalex.org/W4391738654","authors":[],"funders":[{"funder_name":"Region Hovedstaden","grant_id":"A7165","title":null},{"funder_name":"Region Hovedstaden","grant_id":"A7272","title":null},{"funder_name":"Japan Society for Science Promotion Postdoctral Fellowship for Research Abroad","grant_id":"202360405","title":null}],"total_grants":3,"fwci":0.9827,"citation_percentile":0.73521127,"influential_citations":0,"citation_trend":[{"year":2024,"count":2},{"year":2025,"count":1}],"oa_status":"closed","license":"http://onlinelibrary.wiley.com/termsAndConditions#vor","oa_locations":[{"url":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/joim.13771","host_type":"publisher"},{"url":"https://doi.org/10.1111/joim.13771","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/38343109","host_type":"repository"},{"url":"https://researchprofiles.ku.dk/da/publications/95969c12-e002-4ef7-acf9-e071f6b9e84e","host_type":"repository"}],"fields_of_study":["Folate and B Vitamins Research","Parkinson's Disease Mechanisms and Treatments","Ginkgo biloba and Cashew Applications","Humans","Gemfibrozil","Cholesterol, LDL","Fibric Acids","Cholesterol","Hypolipidemic Agents","Triglycerides","Cholesterol, HDL","Lipoproteins, LDL"],"mesh_terms":["Hypolipidemic Agents","Cholesterol","Humans","Cholesterol, HDL","Lipoproteins, LDL","Cholesterol, LDL","Triglycerides","Gemfibrozil","Fibric Acids"],"keywords":["Gemfibrozil","Fibrate","Medicine","Population","Internal medicine","Cholesterol","Endocrinology","Pharmacology","Lipids","Myocardial infarction","Coronary disease","Stroke","Triglycerides‐rich Lipoproteins","Very Low‐density Lipoproteins"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-05T21:15:05.930391Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}